AI Enabled Cardiovascular Disease Risk Prediction through Multimodal Data Fusion: A Predictive Analytics Approach
Main Article Content
Abstract
This study presents a comprehensive framework for cardiovascular disease risk prediction utilizing artificial intelligence-enhanced multimodal data fusion techniques. The proposed approach integrates diverse data modalities including electrocardiographic signals, hemodynamic parameters, laboratory biomarkers, and clinical phenotypes through an adaptive attention-based fusion architecture. Our methodology employs ensemble learning algorithms combined with deep neural networks to construct robust predictive models capable of identifying high-risk populations with superior accuracy compared to traditional risk assessment tools. The framework incorporates advanced feature extraction mechanisms, temporal synchronization protocols, and uncertainty quantification methods to enhance clinical interpretability. Experimental validation demonstrates significant improvements in risk stratification performance, achieving area under curve values exceeding 0.92 across multiple cardiovascular endpoints. The integration of real-time monitoring capabilities with personalized risk profiling enables dynamic assessment of cardiovascular health status, supporting precision medicine initiatives in preventive cardiology. This research contributes to the advancement of intelligent healthcare systems by providing clinicians with enhanced decision-support tools for early intervention strategies and optimized resource allocation in cardiovascular disease management.
Article Details
Section
How to Cite
References
1. M. Van Smeden, et al., “Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease,” Eur. Heart J., vol. 43, no. 31, pp. 2921–2930, 2022, doi: 10.1093/eurheartj/ehac238.
2. J. D. Huang, J. Wang, E. Ramsey, G. Leavey, T. J. Chico, and J. Condell, “Applying artificial intelligence to wearable sensor data to diagnose and predict cardiovascular disease: a review,” Sensors, vol. 22, no. 20, p. 8002, 2022, doi: 10.3390/s22208002.
3. D. A. Adedinsewo, et al., “Cardio-vascular disease screening in women: leveraging artificial intelligence and digital tools,” Circulation Res., vol. 130, no. 4, pp. 673–690, 2022.
4. M. Singh, et al., “Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review,” EClinicalMedicine, vol. 73, 2024.
5. Y. Baashar, G. Alkawsi, H. Alhussian, L. F. Capretz, A. Alwadain, A. A. Alkahtani, & M. Almomani, “Effectiveness of artificial intelligence models for cardiovascular disease prediction: Network meta‐analysis,” Comput. Intell. Neurosci., vol. 2022, no. 1, 5849995, 2022, doi: 10.1155/2022/5849995.
6. Y. Cai, et al., “Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independ-ent validation screening tool: a systematic review,” BMC Med., vol. 22, no. 1, 56, 2024, doi: 10.1186/s12916-024-03273-7.
7. Y. R. Wang, et al., "Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging," Nat. Med., vol. 30, no. 5, pp. 1471–1480, 2024, doi: 10.1038/s41591-024-02971-2.
8. K. C. Siontis, P. A. Noseworthy, Z. I. Attia, & P. A. Friedman, "Artificial intelligence-enhanced electrocardiography in cardio-vascular disease management," Nat. Rev. Cardiol., vol. 18, no. 7, pp. 465–478, 2021, doi: 10.1038/s41569-020-00503-2.
9. A. Sarraju, D. Bruemmer, E. Van Iterson, L. Cho, F. Rodriguez, & L. Laffin, "Appropriateness of cardiovascular disease pre-vention recommendations obtained from a popular online chat-based artificial intelligence model," JAMA, vol. 329, no. 10, pp. 842–844, 2023, doi: 10.1001/jama.2023.1044.
10. A. Lin, M. Kolossváry, M. Motwani, I. Išgum, P. Maurovich-Horvat, P. J. Slomka, & D. Dey, "Artificial intelligence in cardio-vascular imaging for risk stratification in coronary artery disease," Radiology: Cardiothorac. Imaging, vol. 3, no. 1, e200512, 2021, doi: 10.1148/ryct.2021200512.
11. Y. Jiang, C. Wang, & S. Zhou, "Artificial intelligence-based risk stratification, accurate diagnosis and treatment prediction in gynecologic oncology," in Semin. Cancer Biol., vol. 96, pp. 82–99, Academic Press, Nov. 2023, doi: 10.1016/j.semcancer.2023.09.005.
12. D. R. Tovar, M. H. Rosenthal, A. Maitra, & E. J. Koay, "Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer," Artif. Intell. Surg., vol. 3, no. 1, p. 14, 2023, doi: 10.20517/ais.2022.38.
13. G. Tse, et al., "Healthcare Big Data in Hong Kong: Development and implementation of artificial intelligence-enhanced pre-dictive models for risk stratification," Curr. Probl. Cardiol., vol. 49, no. 1, p. 102168, 2024, doi: 10.1016/j.cpcardiol.2023.102168.
14. S. N. Mohsin, et al., "The role of artificial intelligence in prediction, risk stratification, and personalized treatment planning for congenital heart diseases," Cureus, vol. 15, no. 8, 2023, doi: 10.7759/cureus.44374.
15. A. M. Dinani, K. V. Kowdley, & M. Noureddin, "Application of artificial intelligence for diagnosis and risk stratification in NAFLD and NASH: the state of the art," Hepatology, vol. 74, no. 4, pp. 2233–2240, 2021, doi: 10.1002/hep.31869.